Bought
Maintained
Sold
Other funds holding OMCL
ORI
BFA
CCA
CIP
BIT
VVP
UBS's OMCL Position: Q3 2014 in Review
UBS increased its Omnicell (OMCL) stake by 242% in Q3 2014, buying an estimated $390K and bringing the position to 20,116 shares worth $549K. The position accounts for ﹤0.01% of the portfolio, ranked #4168.
UBS first reported a position in OMCL in Q2 2013 and has held it in 6 quarters since. 177 funds tracked by Wall St. Rank hold OMCL as of Q3 2014.
- UBS held 20,116 shares of Omnicell worth $549K as of Q3 2014.
- UBS bought 14,229 Omnicell shares in Q3 2014, an estimated $390K.
- Omnicell made up ﹤0.01% of UBS's portfolio in Q3 2014, its #4168 holding.
- UBS first reported a position in Omnicell in Q2 2013 and has held it in 6 quarters since.
- 177 funds tracked by Wall St. Rank held Omnicell as of Q3 2014.
Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.